National osteopathic professional membership, advocacy, accreditation, certification, and education organization; 501(c)(3)
One uniform surface for comparison; detailed evidence is below.
The score summarizes assessed evidence; evidence coverage is reported separately.
Unaudited annual-report categories. Group and GME membership, certification, accreditation, and conference revenue create distinct payer possibilities that are not disclosed by the accounting labels.
| Accounting category | Amount | Share |
|---|---|---|
| Membership | $12.99M | 37.00% |
| Certification | $10.18M | 29.00% |
| Accreditation | $4.91M | 14.00% |
| OMED | $3.51M | 10.00% |
| Other | $3.51M | 10.00% |
| Total | $35.10M | 100.00% |
Accreditation revenue can be classified broadly as institution-linked. Membership, certification, OMED, and other revenue are not publicly allocated between individuals, employers, programs, sponsors, and other payers.
Primary constituency: Osteopathic physicians, osteopathic medical students, and the osteopathic profession through a physician-led federation; colleges, programs, and certification candidates are material operational constituencies.
Physician alignment: Role dependent: supportive for osteopathic identity, training, payment, and advocacy; mixed where certification revenue, indirect governance, and payer opacity matter.
Funding model: Membership and certification led, with material institutional accreditation and conference revenue; most ultimate payer identity is unclassified.
Primary influence: House of Delegates and Board formally; CEO and staff operationally; membership, certification, and accreditation constituencies financially.
The American Osteopathic Association is a physician-led national organization combining membership, advocacy, accreditation, certification, education, and public-health functions. Richard Thacker became president on July 18, 2026, and CEO Kathleen Creason leads operations under the Board. The 2026 unaudited annual report shows $35.1 million in revenue, concentrated in membership and certification. Group and GME membership and the mixed individual/institutional nature of certification and accreditation mean the accounting categories cannot be treated as individually paid physician support. Current activity is substantially aligned with osteopathic professional identity, payment, training, workforce, payer policy, and public health. The provisional C grade reflects meaningful governance and mission evidence alongside payer opacity, indirect member participation, certification-related incentives, and incomplete sponsor disclosure.
One sentence: AOA is a physician-governed advocate for osteopathic medicine with substantial mission-aligned work, while active-member participation, ultimate payer identity, and sponsor safeguards remain materially uncertain.
Every organization uses the same twelve evidence sections and order.
A national 501(c)(3) professional membership organization that also performs advocacy, education, accreditation and certification functions. [12]
Vision: global leader and unifying home for the osteopathic profession. Mission: advance osteopathic medicine by supporting physicians and students through advocacy, leadership, education, certification, research, innovation, wellness and whole-person care. [2]
Primarily DOs, osteopathic medical students and the osteopathic profession through physician-led House and Board structures. Medical schools, training programs and certification candidates are also important operational constituencies. [3]
| Constituency concept | Evidence-supported answer | Limit |
|---|---|---|
| Formal constituency | Members and delegates within an osteopathic federation; the House of Delegates is the legislative body. | The public record does not establish one-member-one-vote participation. |
| Paying constituency | Individual and group members, certification candidates, accredited institutions/programs, OMED participants, sponsors and other customers appear within revenue-generating activities. | Most ultimate payer classes and concentration are not disclosed. |
| Operational constituency | DOs/students, osteopathic affiliates, certifying boards, colleges/programs and organizational partners. | Relative influence by segment cannot be quantified. |
| Beneficiaries | DOs, students, trainees, medical schools, patients and communities affected by advocacy, standards and public-health work. | Benefit does not establish governance authority or payment. |
| Reach | AOA reports 207,158 DOs and osteopathic medical students in the profession. | This is not a publicly disclosed active, dues-paying or voting membership count. |
| Leader | Current role | Tenure / background | Public compensation | Evidence |
|---|---|---|---|---|
| Richard R. Thacker, DO, MACOI | President | Installed July 18, 2026; internist, educator and former state-association leader. | Current presidential compensation not yet available. FY2025 trustee compensation reported as $3,450. | [4] [5] [12] |
| Bruce A. Wolf, DO | President-elect | Named July 2026; radiologist and academic leader; scheduled to begin presidency July 2027. | FY2025 trustee compensation reported as $2,550. | [4] [5] [12] |
| Teresa A. Hubka, DO | Treasurer | Current elected officer; OB-GYN and prior AOA president. | Current treasurer compensation not yet reported for the new term. | [4] |
| Kathleen S. Creason, MBA | CEO / Board secretary | Board-appointed CEO since July 11, 2023; prior AOiA and state-association executive. | FY2025: $513,238 reportable compensation plus $47,034 other compensation. | [6] [12] |
| Dennis Rizzo | CFO | Appointed officer named in FY2025 filing. | FY2025: $251,681 reportable compensation plus $34,302 other compensation. | [12] |
| Julie Kulovits | General Counsel | Appointed legal officer named in FY2025 filing. | FY2025: $258,410 reportable compensation plus $23,874 other compensation. | [12] |
Confidence: high for formal authority and current titles; moderate for practical influence beyond documented roles. No public evidence was found that a single funder or commercial partner controls policy.
| May 31, 2026 | Amount |
|---|---|
| Cash and investments | $94,239,731 |
| Building and fixed assets | $17,153,096 |
| Other assets | $3,127,401 |
| Total assets | $114,520,228 |
| Deferred revenue | $15,192,271 |
| Accounts payable and accrued expenses | $11,832,781 |
| Total liabilities | $27,025,052 |
| Unrestricted net assets | $75,813,002 |
| Temporarily restricted net assets | $11,682,174 |
| Total net assets | $87,495,176 |
| Fiscal year ended May 2025 | Amount | Share |
|---|---|---|
| Total revenue | $35,774,516 | 100% |
| Program-service revenue | $32,429,099 | 90.6% |
| Contributions | $887,411 | 2.5% |
| Investment income | $2,071,852 | 5.8% |
| Total expenses | $35,070,149 | - |
| Net income | $704,367 | - |
| Net assets | $81,503,076 | - |
Advocacy spending context: The FY2026 annual report assigns 8% of operating expenses ($2.8M) to Government Relations, a broader operating category than legally reportable lobbying. AOA’s membership FAQ estimates 3.91% of dues is used for lobbying. [1] [11]
| Revenue category | Reported amount | What public records establish | What they do not establish |
|---|---|---|---|
| Membership · 37% | $12.987M | AOA receives membership revenue; regular, discounted, group and GME pathways exist. | Individual-paid vs employer/institution-paid shares; top payers; active dues-paying member count. |
| Certification · 29% | $10.179M | Certification is a major revenue-generating service. | Candidate-paid vs reimbursed shares; payer concentration; margins by board. |
| Accreditation · 14% | $4.914M | An institutional payer class is identifiable at a broad level. | Which colleges/programs paid how much; concentration among institutions. |
| OMED · 10% | $3.510M | Conference-related revenue exists. | Registration, exhibits, sponsorship and other components; ultimate payer classes. |
| Other · 10% | $3.510M | A residual accounting category exists. | Component sources and payer identity. |
Unknown
Regular dues are published, but aggregate personally paid dues are not.
Unknown
Group membership is available, but aggregate health-system payments are not disclosed.
Unknown
No reliable public aggregate was found.
Relationships documented; amounts unknown
Pfizer, Astellas, Merck and Sanofi are publicly named partners; amounts and firewalls were not found.
Unknown as a payer class
Advocacy and accreditation recognition are documented, but a current aggregate government funding figure was not found.
2.5% of FY2025 revenue
Low charitable-gift share does not establish low customer or program-payer concentration.
Top-one and top-three payer concentration: unknown. Largest identifiable payer class: institutional accreditation payers at 14%, at broad class level only. Confidence: high that payer identity is not publicly classifiable; low regarding any inference about actual independence.
| Entity / function | Legal or operational status | Relationship | Financial treatment in this review |
|---|---|---|---|
| American Osteopathic Association | 501(c)(3) public charity / professional organization | Parent organization reviewed here. | AOA operating statements and Form 990 used. |
| Commission on Osteopathic College Accreditation (COCA) | AOA accrediting commission | Recognized nationwide by the U.S. Department of Education. [13] | Accreditation revenue/expense treated as AOA activity. |
| AOA certifying boards | AOA certification functions | Provide specialty board certification. | Certification revenue/expense treated as AOA activity. |
| American Osteopathic Information Association (AOiA) | Separate 501(c)(6) business league / trade association | Supports technology, physician services and OPAC-related activity. [19] [28] | AOiA revenue and assets are not combined with AOA. |
| Osteopathic Political Action Committee (OPAC) | Separate federal political committee connected to AOiA | Receives political contributions and makes political disbursements. [20] | Not combined with AOA operating revenue or expenses. |
| American Osteopathic Foundation (AOF) | Separate charitable foundation | Joint corporate partnership page with AOA; funds scholarships and initiatives. [18] [21] | AOF gifts and assets are not automatically AOA revenue. |
| Person / institution / relationship | Influence classification | Evidence-supported basis | Boundary |
|---|---|---|---|
| House of Delegates and constituent affiliates | Directly documented | Legislative authority; elects officers and trustees; approves policy and dues-related actions. | Delegate selection and participation rates are not publicly quantified in this review. |
| Board of Trustees | Directly documented | Administrative and executive body; appoints key executives. | Individual trustee influence beyond formal votes is not inferred. |
| CEO and executive staff | Directly documented | Operational authority, program execution, finance, legal, membership and government relations. | Staff authority remains accountable to Board structure. |
| Certification and accreditation customers | Strong inference | Together account for 43% of FY2026 revenue and are core mission functions. | Revenue dependence does not prove policy control; payer concentration is unknown. |
| Individual and organization-paid members | Directly documented relationship | Membership is the largest revenue category and members participate through governance channels. | The split between individual and organization-paid support is unknown. |
| Pfizer, Astellas, Merck and Sanofi | Directly documented relationship | Named AOA/AOF corporate partners. | Amounts, restrictions and decision firewalls were not found; control is not established. |
| AOiA / OPAC | Directly documented relationship | Affiliated ecosystem and separate political activity. | Separate legal and financial entities; political spending is not AOA operating spending. |
| Unnamed hospitals, insurers, PBMs or manufacturers | Excluded | No sufficiently specific payer or control evidence found. | Possible relationships are not listed as influencers without evidence. |
| Stated commitment | Relevant action or omission | Assessment | Confidence / evidence |
|---|---|---|---|
| Support physicians through advocacy | AOA reports advocacy contributing to a 2.5% Medicare payment increase for 2026, telehealth extension, Lorna Breen Act renewal and workforce funding; DO Day reached 321 congressional offices. | Supported | Moderate-high; outcomes documented, but multi-actor policy wins cannot be attributed solely to AOA. [1] [14] |
| Advance distinctive osteopathic practice | Secured report language encouraging CMS support for osteopathic manipulative treatment and challenged an ABIM program-director attestation policy. | Supported | High that actions occurred; legal merits remain unresolved. [15] [24] [25] |
| Support physician practice and payer fairness | Private-payer advocacy contributed to postponement of a BCBS Michigan modifier-25 policy. | Supported | Moderate; specific outcome documented, broader national effect not established. [16] |
| Promote public health | Public statements support routine and emergent immunization and evidence-based vaccine policy. | Supported | High for stated position; downstream outcome not assessed. [17] |
| Member accountability | Governance documents, current leaders, dues rates, annual report and tax filing are public. | Partially supported | High; active member count, delegate participation, payer classes and sponsor amounts remain undisclosed. |
| Certification as professional service | A 2018 settlement permanently decoupled certification from mandatory AOA membership and provided additional relief. | Historical inconsistency remediated | High; allegations were not adjudicated and AOA denied wrongdoing. [22] [23] |
| Physician role | Label | Strongest support | Strongest contrary fact / limitation | Confidence |
|---|---|---|---|---|
| Individual DO | Mixed | Broad advocacy, education and DO recognition. | Indirect governance and unknown individual-vs-organization payer mix. | Moderate |
| Employed DO | Mixed | Payment, noncompete, well-being and burden advocacy. | Employer-paid membership may create institutional paying constituencies; independent physician input is not quantified. | Moderate |
| Independent / owner DO | Mixed | Payer-policy and payment advocacy; practice resources. | Comprehensive ownership/consolidation agenda not demonstrated. | Moderate |
| Physician executive / group leader | Supportive | National advocacy, accreditation, data, governance and leadership infrastructure. | Institutional benefit does not equal benefit to every employed physician. | Moderate |
| Primary care DO | Supportive | Payment, telehealth, workforce and rural/underserved priorities. | Specialty representation among active voters is not disclosed. | Moderate |
| Specialist / procedural DO | Mixed | Certification, credentialing and payment advocacy. | Certification is a major revenue center and its payer/burden distribution is incomplete. | Moderate |
| Rural / community DO | Supportive | Workforce, telehealth and underserved-care advocacy. | Segment-specific outcome data are limited. | Moderate |
| Academic DO | Mixed | Accreditation, research, training and program-director advocacy. | Institutional accreditation incentives can differ from faculty or trainee interests. | Moderate |
| Trainee / early-career DO | Supportive | Dedicated Board seats, low-cost membership, training and credentialing advocacy. | Limited proportional governance seats; program-paid participation may blur payer identity. | Moderate-high |
| Issue | Label | Affected segment | Evidence basis | Confidence |
|---|---|---|---|---|
| Payment and financial sustainability | Supportive | Broad physician population | Medicare payment, laboratory and payer advocacy. | High for action; moderate for attribution |
| Administrative burden / prior authorization / payer policy | Supportive | Practicing physicians | Private-payer resources and documented modifier-25 intervention. | Moderate |
| Employment mobility and noncompetes | Supportive | Employed physicians | Specific state-level advocacy reported in annual report. | Moderate |
| Certification and professional autonomy | Mixed | Board-certified DOs and trainees | Current defense of osteopathic certification pathways; historical membership tie was remedied. | Moderate-high |
| Independent-practice viability | Mixed | Independent physicians | Payment/payer work helps; comprehensive consolidation or ownership agenda not demonstrated. | Moderate-low |
| Education and training | Supportive | Students, trainees, educators | Accreditation, CME, GME and program-director advocacy. | High |
| Scope, licensure and credentialing | Supportive for DO recognition | DOs and trainees | National/state advocacy and ABIM litigation. | Moderate-high |
| Rural and underserved care | Supportive | Rural/community physicians and patients | Workforce, telehealth and training priorities. | Moderate |
| Workforce well-being | Supportive | Physicians and trainees | Lorna Breen Act and wellness programming. | Moderate |
| Practice ownership and consolidation | Not demonstrated | Independent and employed physicians | No sufficiently comprehensive current policy record found in reviewed sources. | Low |
| Patient care and public health | Supportive | Physicians and patients | Whole-person care, immunization, OMT and public-health positions. | Moderate-high |
| Matter | AOA role | Status and result | Mission relevance | Assessment |
|---|---|---|---|---|
| Talone et al. v. AOA D.N.J. No. 1:16-cv-04644 | Defendant | Court approved settlement Dec. 3, 2018. AOA permanently decoupled board certification from membership, provided fee/dues/CME relief and a private-practice task force. AOA denied liability; no fault was adjudicated. [22] [23] | Certification, competition, member choice and governance. | Material historical concern · remediated |
| AOA et al. v. ABIM N.D. Ill. No. 1:25-cv-14691 | Plaintiff | July 20, 2026 order dismissed Counts I–III without prejudice; Count IV monopolization claim survived the motion to dismiss. Pleading stage; no merits finding. [24] [25] | DO credentialing, competition and program-director autonomy. | Current advocacy litigation · unresolved |
| COCA recognition | Accrediting organization | U.S. Department of Education recognizes COCA nationwide for osteopathic medical education accreditation; recognition record current through 2026. [13] | Educational standards and public accountability. | Favorable regulatory evidence |
| FY2025 Schedule L indicator | Tax filer | IRS-derived summary indicates reportable interested-person transactions on Schedule L. Transaction-specific facts were not fully extracted for this review. | Conflict disclosure and related-party transparency. | Disclosure flag · no misconduct inference |
| Code of Ethics | Publisher / policy body | Public Code of Ethics page states last update July 24, 2016. [26] | Ethical standards and policy freshness. | Freshness limitation |
The Evidence & Accountability Grade follows the supplied Blair Compass rubric. It is not a moral verdict, endorsement, accusation or physician-support score.
| Dimension | Weight | Score | Confidence | Rationale |
|---|---|---|---|---|
| Financial transparency and source identification | 15 | 9 | Moderate | Timely totals and category mix; weak ultimate-payer, sponsor and membership-payment disclosure. |
| Funding independence and concentration risk | 15 | NE | Low | Ultimate payer concentration cannot be assessed; this dimension is excluded rather than scored down. |
| Mission-to-action alignment | 20 | 17 | High | Substantial documented advocacy, education, certification and public-health action. |
| Physician/member governance and representation | 15 | 11 | High | Clear physician-led House/Board structure; indirect delegate model and participation data gaps. |
| Breadth across physician segments | 10 | 7 | Moderate | Broad programs and advocacy; uneven segment-level outcome and representation data. |
| Leadership, conflict management and accountability | 10 | 7 | Moderate | Clear roles and policies; limited sponsor firewall and transaction-level disclosure. |
| Legal, regulatory and ethical record | 10 | 8 | Moderate-high | Favorable accreditation recognition; historical settlement remediated; no severe current finding. |
| Outcomes and public accountability | 5 | 4 | Moderate | Multiple documented outcomes and public reporting, with attribution limits. |
Grade bands: A 90–100; B 80–89; C 70–79; D 60–69; F below 60; NE insufficient evidence.
Publication status: Public review. A last-link check and final editorial approval are required before each release.
Organization review: The reviewed organization did not approve, edit, or veto the score. A factual correction process is described on the Blair Compass methodology and corrections pages.
Scope: Verification is limited to publicly accessible records. Private contracts, nonpublic minutes, sealed proceedings, and undisclosed conflicts are outside the available evidence.
Source rule: Primary and official records were preferred. Accounting categories were not converted into payer identities. Related entities were kept separate. Allegations were not treated as findings.
Verification: current leaders and major financial arithmetic were checked for this publication batch. Material corrections and future updates follow the published verification process.
